The Carlyle Group Invests in MAK-SYSTEM

February 20, 2020

The Carlyle Group has made a significant investment in MAK-SYSTEM, a family-owned provider of blood management software, partnering with the Kiskovski family to accelerate the company’s growth. Carlyle’s equity commitment comes from Carlyle Europe Partners V and Carlyle Europe Technology Partners IV and will support product innovation and international expansion; Philippe Houssiau has been named CEO. Financial terms were not disclosed.

Buyers
The Carlyle Group
Targets
MAK-SYSTEM
Location
North Macedonia
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.